학술논문

Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer patients: A multicentre, randomised Phase III study by the Piemonte Oncology Network
Document Type
Article
Source
In: European Journal of Cancer. (European Journal of Cancer, September 2021, 155:127-135)
Subject
Language
English
ISSN
18790852
09598049